search

Microbot Medical Inc (MBOT)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Microbot Medical (MBOT) Stock Sees Fair Value Cut As Liberty Adoption Outlook Softens
Nov 3, 2026

Microbot Medical (MBOT) Stock Sees Fair Value Cut As Liberty Adoption Outlook Softens

The fair value estimate for Microbot Medical (MBOT) has been reduced by 15%, from US$6.33 to US$5.38, due to a more cautious outlook on the adoption rate of its Liberty system by hospitals. Analysts, while maintaining "Buy" ratings, have recalibrated their price targets, citing slower system-level approvals and the relatively small near-term commercialization numbers for the Liberty platform. This adjustment reflects updated assumptions regarding projected revenue growth, net profit margin, and future P/E multiples.
Company relevance
100.00%
Company sentiment
Somewhat-Bearish
Overall sentiment
Somewhat-Bearish